Papers

2

Total Citations

5

H-Index

2

About

Noud van Helmond is a clinical researcher specializing in regional anesthesia and perioperative pain management, with a focus on optimizing analgesic techniques for thoracic surgery. His work centers on comparing novel nerve block modalities to improve postoperative outcomes and reduce opioid reliance. In a landmark 2024 randomized clinical trial, van Helmond investigated liposomal bupivacaine versus standard bupivacaine with dexamethasone for intercostal nerve blocks in robotic thoracic surgery, demonstrating how adjuvant formulations can enhance pain control. His 2022 retrospective analysis further advanced the field by evaluating serratus anterior plane blocks against traditional intercostal nerve blocks, providing critical evidence for procedural selection. Though early in his career, van Helmond’s research has already garnered attention, with his most-cited papers accumulating citations that underscore their clinical relevance. His work directly addresses the pressing need for multimodal analgesia strategies, offering surgeons and anesthesiologists data-driven guidance for reducing postoperative pain and improving recovery. Van Helmond’s contributions are particularly valuable for trainees and practitioners seeking evidence-based approaches to regional anesthesia in minimally invasive thoracic procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Liposomal Bupivacaine Versus Bupivacaine and Dexamethasone Intercostal Nerve Blocks for Robotic Thoracic Surgery: A Randomized Clinical Trial
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Cooper University Hospital, Cooper Medical School of Rowan University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago